Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.
about
Efflux-mediated drug resistance in bacteria: an updateDissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant BacteriaCosts of antibiotic resistance - separating trait effects and selective effectsInterplay in the selection of fluoroquinolone resistance and bacterial fitnessMathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excretedStrain Dependent Genetic Networks for Antibiotic-Sensitivity in a Bacterial Pathogen with a Large Pan-GenomePlasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa.Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.Reversibility of antibiotic resistancePlasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure.Selection of target mutation in rat gastrointestinal tract E. coli by minute dosage of enrofloxacin.The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urineGenomewide screen for modulators of evolvability under toxic antibiotic exposure.Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections.Fitness cost of antibiotic susceptibility during bacterial infection.Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.A fluoroquinolone resistance associated mutation in gyrA Affects DNA supercoiling in Campylobacter jejuniSelection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome.Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections.Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype.Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure.Antimicrobial resistances do not affect colonization parameters of intestinal E. coli in a small piglet group.Effect of Trehalose and Trehalose Transport on the Tolerance of Clostridium perfringens to Environmental Stress in a Wild Type Strain and Its Fluoroquinolone-Resistant Mutant.Overview of strategies for overcoming the challenge of antimicrobial resistance.Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.Spontaneous and on point: Do spontaneous mutations used for laboratory experiments cause pleiotropic effects that might confound bacterial infection and evolution assays?Resistance mechanisms and fitness of Salmonella Typhimurium and Salmonella Enteritidis mutants evolved under selection with ciprofloxacin in vitro.Prediction of antibiotic resistance: time for a new preclinical paradigm?Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coliEnvironmental and genetic modulation of the phenotypic expression of antibiotic resistance.Fisher's geometrical model and the mutational patterns of antibiotic resistance across dose gradients.Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.Fluoroquinolone resistance does not impose a cost on the fitness of Clostridium difficile in vitro.Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli.Nonoptimal DNA topoisomerases allow maintenance of supercoiling levels and improve fitness of Streptococcus pneumoniae.Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development.
P2860
Q24609407-0A9CFE86-59EE-4CF2-9F33-5DB4F718D548Q26741585-292B04C5-E885-4535-A486-8DE27F2ABE34Q28082095-7307DDCC-520C-40F8-8175-6EE04E359E41Q28475870-D871ED93-D65C-4892-9B8E-0431AF451351Q28542920-ABC671E6-EE8A-47E8-9A4E-2DF01158C66DQ28553946-E22B02DF-A582-4BC2-8E84-DA87B9531F28Q30240591-0656B38B-ED1E-4E0A-AC12-FD309D469A50Q30882914-CC490B79-383F-4142-87EA-9FB9A0268FABQ33264145-46A54E09-099C-40FE-B2BF-087F9AD087A2Q33667524-7247B5FB-A9B2-4713-BFD1-B1B29D23D8A8Q34019104-9EBBEA80-D785-45AF-8577-B6374ECC13CDQ34133191-1EB4CEA6-B043-4979-BD27-106F0718824CQ34301103-7D4CF756-2A5F-4DF0-9C9B-01FCA892E6D7Q34719336-F58B3039-4D9E-4C2F-B63D-B571C5D1646DQ35086017-F940D232-7F15-4D16-8D47-877F5D6F8DB1Q35707529-03E17286-1319-4C3E-BAF8-EF9F4F7A0B31Q36154055-F4CF4DF4-26CF-45E1-9E93-880A4E03172AQ36159080-FC6CEA4A-1236-4CC6-90DD-99D4E0EBFD35Q36932972-FBF051A1-7F21-41EC-90A6-EA7288619B6DQ37074679-4C308E4B-EABE-4C87-A511-64F8A889710CQ37115768-FE2E7DAB-EA4B-4DBB-A947-38413F003A9EQ37306380-D2A7DE3E-56CA-4CE6-B2C1-B6E50B73462CQ37379658-27D90F80-BF19-4DA0-8D80-FC938A8EC26BQ37397628-86073E86-BFAE-4555-BB9A-9AE0C7A62D65Q37531898-126EA855-3E33-4DE8-B461-EA83B5F6EDEDQ37960104-48530A40-E3FE-48AA-96F0-B4522DE82B84Q38543385-47AC1818-DA2D-4AF8-BD4B-C891ECC569B0Q38595570-026E146B-9F4E-4BB0-BEBA-E71459A5F61AQ38613323-1EDD5A84-C66F-465A-B6F1-E37FB4D6DCF5Q38649580-209D0DE0-9503-409E-A88A-A646C44B6171Q38724103-6831FE2B-B033-4AB1-B441-F384EC5A7571Q39020968-26E46A61-56AD-47D8-B4FE-E3F9B294CCCFQ39195574-76CDCB7D-7DF1-4309-A5D9-E2706F237D6EQ39224677-3A70B6A4-AA27-4C3A-8A0D-09C3D50D3655Q40599029-4F1F0DDD-7197-43F3-8A52-A7FC9909D340Q41585335-E3E8E977-3614-43F5-8D04-15BB4DD8217CQ41788804-9C3E3C44-48AE-45B7-80A8-2A4E2E89B5D8Q42111122-8C318E5E-D156-4AD5-9FD2-FF38A21E5EA7Q42201141-5C7C07AC-91FB-4932-81E4-89D52D10D8F0Q42246515-B95EE078-B8E0-4408-8F78-D764987DB9BD
P2860
Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Biological cost of single and ...... d in urinary tract infections.
@ast
Biological cost of single and ...... d in urinary tract infections.
@en
type
label
Biological cost of single and ...... d in urinary tract infections.
@ast
Biological cost of single and ...... d in urinary tract infections.
@en
prefLabel
Biological cost of single and ...... d in urinary tract infections.
@ast
Biological cost of single and ...... d in urinary tract infections.
@en
P2093
P2860
P1476
Biological cost of single and ...... ed in urinary tract infections
@en
P2093
Dorthe Sandvang
Linda L Marcusson
Niels Frimodt-Møller
Patricia Komp Lindgren
P2860
P304
P356
10.1128/AAC.49.6.2343-2351.2005
P407
P577
2005-06-01T00:00:00Z